|
시장보고서
상품코드
1986547
전체 슬라이드 이미징 시장 보고서 : 기술별, 용도별, 최종사용자별, 지역별(2026-2034년)Whole Slide Imaging Market Report by Technology, Application, End User, and Region 2026-2034 |
||||||
세계의 전체 슬라이드 이미징 시장 규모는 2025년에 9억 3,320만 달러에 달했습니다. 향후 IMARC Group은 2034년까지 시장 규모가 21억 5,600만 달러에 달하고, 2026년부터 2034년까지 CAGR 9.46%로 성장할 것으로 예측했습니다.
전체 슬라이드 이미징(WSI)은 유리 슬라이드를 스캔하여 조직 절편의 고해상도 및 정밀한 디지털 이미지를 생성하는 기술입니다. 여기에는 초점 조절 장치, 카메라, 조명 시스템, 스캐너, 뷰어, 이미지 관리 시스템 및 현미경용 광학 부품이 포함됩니다. WSI는 전용 스캐너를 사용하여 유리 슬라이드를 디지털화하고, 가상 슬라이드 뷰어를 통해 분석, 저장, 공유되는 고해상도 디지털 이미지를 생성합니다. 면역조직화학, 원격 병리진단, 혈액병리학 및 세포병리학에 널리 활용되고 있습니다. WSI는 분석의 정확성과 속도 향상, 생산성 향상, 오류 감소, 신뢰성 있고 편리한 결과 제공을 지원합니다. 그 결과, 학계 및 연구기관, 생명공학 기업 및 제약회사, 병원 및 진료소 등에서 널리 활용되고 있습니다.
전체 슬라이드 이미징 시장 동향:
의료 산업의 괄목할만한 성장과 전 세계적으로 환자 안전에 대한 관심이 높아지면서 시장 전망을 밝게 하는 주요 요인이 되고 있습니다. 또한, 생활습관의 변화, 유전자 변이, 흡연 및 음주 습관의 증가로 인한 암 유병률 증가도 시장 성장을 촉진하고 있습니다. 이에 따라 WSI는 피부암, 폐암, 유방암이 의심되는 경우 진단 절차에 널리 사용되고 있으며, 이는 시장 성장을 더욱 촉진하고 있습니다. 또한, 다양한 질병과 진단을 지원하고 정밀의료 제공을 가능하게 하는 인공지능(AI)과 머신러닝(ML)의 통합과 같은 기술적 진보가 시장 성장에 큰 탄력을 받고 있습니다. 이에 따라 조직 샘플의 단백질 발현을 관찰하고 세포 내 항원을 검출하기 위한 면역조직화학(IHC)에서 전체 슬라이드 이미징의 보급이 시장 성장에 긍정적인 영향을 미치고 있습니다. 이 밖에도 신약개발 분야의 제품 수요 증가, 광범위한 연구개발(R&D) 활동 등의 요인도 시장 성장을 견인할 것으로 예상됩니다.
목차
제1장 서문
제2장 조사 범위와 조사 방법
제3장 주요 요약
제4장 소개
제5장 세계의 전체 슬라이드 이미징 시장
제6장 시장 내역 : 기술별
제7장 시장 내역 : 용도별
제8장 시장 내역 : 최종사용자별
제9장 시장 내역 : 지역별
제10장 SWOT 분석
제11장 밸류체인 분석
제12장 Porter's Five Forces 분석
제13장 가격 분석
제14장 경쟁 구도
KSMThe global whole slide imaging market size reached USD 933.2 Million in 2025. Looking forward, IMARC Group expects the market to reach USD 2,156.0 Million by 2034, exhibiting a growth rate (CAGR) of 9.46% during 2026-2034.
Whole slide imaging (WSI) is scanning glass slides used to produce high-resolution and precise digital images of tissue sections. It comprises a focusing unit, camera, illumination systems, scanners, viewers, image management system, and microscopic optical components. WSI utilizes a specialized scanner to digitize glass slides and generate large digital images that are analyzed, stored, and shared through the virtual slide viewer. It is widely used in immunohistochemistry, telepathology, hematopathology, and cytopathology. WSI assists in improving accuracy, speed of analysis, increasing productivity, reducing errors, and providing reliable and convenient results. As a result, it is widely used across academic and research institutes, biotechnology and pharmaceutical companies, and hospitals and clinics.
WHOLE SLIDE IMAGING MARKET TRENDS:
The significant growth in the healthcare industry and the rising focus on patient safety across the globe are the prime factors creating a positive outlook for the market. Additionally, the rising prevalence of cancer due to the changing lifestyles, genetic mutation, and increasing smoking and alcohol habits is favoring the market growth. In line with this, WSI is extensively used in diagnostic procedures for suspected skin, lungs, and breast cancer, which is further providing an impetus to the market growth. Moreover, various technological advancements, such as the integration of artificial intelligence (AI) and machine learning (ML) to assist in various diseases and diagnoses and provide precision medicine delivery, are providing a considerable boost to the market growth. In line with this, the widespread adoption of whole slide imaging in immunohistochemistry (IHC) to observe protein expression in tissue samples and detect antigens in the cells is positively impacting the market growth. Other factors, such as the increasing product demand in drug discovery and extensive research and development (R&D) activities, are anticipated to drive the market growth.
KEY MARKET SEGMENTATION:
Breakup by Technology:
- Scanners
- IT Infrastructure
- Viewer
- Image Management System
Breakup by Application:
- Immunohistochemistry
- Telepathology
- Cytopathology
- Hematopathology
Breakup by End User:
- Academic Institute
- Research
- Others
Breakup by Region:
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
COMPETITIVE LANDSCAPE:
The report provides a comprehensive analysis of the competitive landscape in the global whole slide imaging market with detailed profiles of all major companies, including:
- 3DHISTECH Ltd.
- Akoya Biosciences, Inc
- Evident Scientific
- F. Hoffmann-La Roche Ltd
- Hamamatsu Photonics K.K.
- Huron Technologies International Inc.
- Leica Biosystems
- Mikroscan Technologies, Inc.
- Motic Digital Pathology
- OptraSCAN Inc.
- Visiopharm A/S
KEY QUESTIONS ANSWERED IN THIS REPORT
1. How big is the whole slide imaging market?
2. What is the future outlook of whole slide imaging market?
3. What are the key factors driving the whole slide imaging market?
4. Which region accounts for the largest whole slide imaging market share?
5. Which are the leading companies in the global whole slide imaging market?
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Whole Slide Imaging Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Technology
- 6.1 Scanners
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 IT Infrastructure
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
- 6.3 Viewer
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
- 6.4 Image Management System
- 6.4.1 Market Trends
- 6.4.2 Market Forecast
7 Market Breakup by Application
- 7.1 Immunohistochemistry
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Telepathology
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
- 7.3 Cytopathology
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
- 7.4 Hematopathology
- 7.4.1 Market Trends
- 7.4.2 Market Forecast
8 Market Breakup by End User
- 8.1 Academic Institute
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Research
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
- 8.3 Others
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
9 Market Breakup by Region
- 9.1 North America
- 9.1.1 United States
- 9.1.1.1 Market Trends
- 9.1.1.2 Market Forecast
- 9.1.2 Canada
- 9.1.2.1 Market Trends
- 9.1.2.2 Market Forecast
- 9.1.1 United States
- 9.2 Asia-Pacific
- 9.2.1 China
- 9.2.1.1 Market Trends
- 9.2.1.2 Market Forecast
- 9.2.2 Japan
- 9.2.2.1 Market Trends
- 9.2.2.2 Market Forecast
- 9.2.3 India
- 9.2.3.1 Market Trends
- 9.2.3.2 Market Forecast
- 9.2.4 South Korea
- 9.2.4.1 Market Trends
- 9.2.4.2 Market Forecast
- 9.2.5 Australia
- 9.2.5.1 Market Trends
- 9.2.5.2 Market Forecast
- 9.2.6 Indonesia
- 9.2.6.1 Market Trends
- 9.2.6.2 Market Forecast
- 9.2.7 Others
- 9.2.7.1 Market Trends
- 9.2.7.2 Market Forecast
- 9.2.1 China
- 9.3 Europe
- 9.3.1 Germany
- 9.3.1.1 Market Trends
- 9.3.1.2 Market Forecast
- 9.3.2 France
- 9.3.2.1 Market Trends
- 9.3.2.2 Market Forecast
- 9.3.3 United Kingdom
- 9.3.3.1 Market Trends
- 9.3.3.2 Market Forecast
- 9.3.4 Italy
- 9.3.4.1 Market Trends
- 9.3.4.2 Market Forecast
- 9.3.5 Spain
- 9.3.5.1 Market Trends
- 9.3.5.2 Market Forecast
- 9.3.6 Russia
- 9.3.6.1 Market Trends
- 9.3.6.2 Market Forecast
- 9.3.7 Others
- 9.3.7.1 Market Trends
- 9.3.7.2 Market Forecast
- 9.3.1 Germany
- 9.4 Latin America
- 9.4.1 Brazil
- 9.4.1.1 Market Trends
- 9.4.1.2 Market Forecast
- 9.4.2 Mexico
- 9.4.2.1 Market Trends
- 9.4.2.2 Market Forecast
- 9.4.3 Others
- 9.4.3.1 Market Trends
- 9.4.3.2 Market Forecast
- 9.4.1 Brazil
- 9.5 Middle East and Africa
- 9.5.1 Market Trends
- 9.5.2 Market Breakup by Country
- 9.5.3 Market Forecast
10 SWOT Analysis
- 10.1 Overview
- 10.2 Strengths
- 10.3 Weaknesses
- 10.4 Opportunities
- 10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
- 12.1 Overview
- 12.2 Bargaining Power of Buyers
- 12.3 Bargaining Power of Suppliers
- 12.4 Degree of Competition
- 12.5 Threat of New Entrants
- 12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
- 14.1 Market Structure
- 14.2 Key Players
- 14.3 Profiles of Key Players
- 14.3.1 3DHISTECH Ltd.
- 14.3.1.1 Company Overview
- 14.3.1.2 Product Portfolio
- 14.3.2 Akoya Biosciences, Inc
- 14.3.2.1 Company Overview
- 14.3.2.2 Product Portfolio
- 14.3.2.3 Financials
- 14.3.2.4 SWOT Analysis
- 14.3.3 Evident Scientific
- 14.3.3.1 Company Overview
- 14.3.3.2 Product Portfolio
- 14.3.3.3 Financials
- 14.3.3.4 SWOT Analysis
- 14.3.4 F. Hoffmann-La Roche Ltd
- 14.3.4.1 Company Overview
- 14.3.4.2 Product Portfolio
- 14.3.4.3 Financials
- 14.3.5 Hamamatsu Photonics K.K.
- 14.3.5.1 Company Overview
- 14.3.5.2 Product Portfolio
- 14.3.5.3 Financials
- 14.3.5.4 SWOT Analysis
- 14.3.6 Huron Technologies International Inc.
- 14.3.6.1 Company Overview
- 14.3.6.2 Product Portfolio
- 14.3.7 Leica Biosystems
- 14.3.7.1 Company Overview
- 14.3.7.2 Product Portfolio
- 14.3.7.3 Financials
- 14.3.7.4 SWOT Analysis
- 14.3.8 Mikroscan Technologies, Inc.
- 14.3.8.1 Company Overview
- 14.3.8.2 Product Portfolio
- 14.3.9 Motic Digital Pathology
- 14.3.9.1 Company Overview
- 14.3.9.2 Product Portfolio
- 14.3.9.3 Financials
- 14.3.9.4 SWOT Analysis
- 14.3.10 OptraSCAN Inc.
- 14.3.10.1 Company Overview
- 14.3.10.2 Product Portfolio
- 14.3.10.3 Financials
- 14.3.10.4 SWOT Analysis
- 14.3.11 Visiopharm A/S
- 14.3.11.1 Company Overview
- 14.3.11.2 Product Portfolio
- 14.3.1 3DHISTECH Ltd.
